Status:

COMPLETED

Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease

Lead Sponsor:

University of Florida

Conditions:

Coronary Artery Disease

Eligibility:

All Genders

18-80 years

Phase:

PHASE4

Brief Summary

The recommended antiplatelet treatment regimen for patients affected by acute coronary syndromes (ACS) and those undergoing percutaneous coronary intervention (PCI) consists in the combination of aspi...

Detailed Description

The recommended antiplatelet treatment regimen for patients affected by acute coronary syndromes (ACS) and those undergoing percutaneous coronary intervention (PCI) consists in the combination of aspi...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Patients with angiographically documented CAD
  • On therapy with aspirin(\<100mg/day) and clopidogrel (75mg/day) for at least 30 days per standard of care
  • Age between 18 and 80 years old
  • Exclusion Criteria
  • History of intracranial bleeding
  • Severe hepatic impairment (ALT \>2.5 times the upper limit of normal)
  • Active bleeding or propensity to bleed or blood dycrasia
  • Platelet count \<80x106/mL
  • Hemoglobin \<10g/dL
  • Hemodynamic instability
  • Estimated glomerular filtration rate (eGFR) \<30 mL/min
  • On treatment with oral anticoagulants
  • Patients with sick sinus syndrome (SSS) or II or III degree AV block without pacemaker protection
  • Drugs interfering CYP3A4 metabolism (to avoid interaction with ticagrelor): ketoconazole, itraconazole, voriconazole, clarithromicin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromizycin
  • Pregnant females \[women of childbearing age must use reliable birth control (i.e. oral contraceptives) while participating in the study\].

Exclusion

    Key Trial Info

    Start Date :

    December 1 2014

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    March 1 2018

    Estimated Enrollment :

    87 Patients enrolled

    Trial Details

    Trial ID

    NCT02287909

    Start Date

    December 1 2014

    End Date

    March 1 2018

    Last Update

    September 16 2020

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Florida

    Jacksonville, Florida, United States, 32209

    Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease | DecenTrialz